key: cord-0841623-ek5wz75f
authors: Che, Li; Song, Wei; Zhang, Ying; Lu, Yan; Cheng, Yunpeng; Jiang, Yinong
title: A randomized, double‐blind clinical trial to evaluate the blood pressure lowing effect of low‐sodium salt substitution on middle‐aged and elderly hypertensive patients with different plasma renin concentrations
date: 2021-12-29
journal: J Clin Hypertens (Greenwich)
DOI: 10.1111/jch.14396
sha: 9e414fff80b6ed1d7f19c507c5ee554db2360e15
doc_id: 841623
cord_uid: ek5wz75f

This study aimed to evaluate the blood pressure (BP) lowing effect of low‐sodium (LS) salt substitution and how the effect influenced by plasma renin concentration (PRC) on middle‐aged and elderly hypertensive patients. Three hundred fifty‐two hypertensives were randomized at a 1:1 ratio into a LS group and a normal salt (NS) group. We compared intergroup changes observed in office blood pressure measurement (OBPM) and home blood pressure measurement (HBPM). Then, all patients in LS group were divided into tertiles according to baseline PRC, aldosterone concentration, and aldosterone/renin ratio (ARR), and changes in OBPM and HBPM were compared across the three tertile subgroups. Follow‐up surveys were completed by 322 patients. The intergroup net reduction in systolic OBPM, systolic HBPM, and diastolic HBPM was −6.6, −4.6, and −2.3 mmHg, respectively (all P < .05), and −1.8 mmHg in diastolic OBPM (P = .068). There was a more significant reduction in OBPM and HBPM among the low baseline PRC subgroup than among the high PRC subgroup. There were no significant differences in the changes in OBPM and HBPM between the three subgroups when grouped according to baseline aldosterone concentration. The reduction in OBPM and HBPM in the high tertile of ARR was larger than that in the low tertile subgroup. LS salt substitution is effective in reducing systolic OBPM, systolic HBPM, and diastolic HBPM in middle‐aged and elderly hypertensive patients. LS salt substitution may offer a non‐pharmaceutical therapy for hypertensive patients. Baseline PRC may be a marker to predict BP response after salt restriction.

High blood pressure (BP) is a major preventable risk factor for heart disease, kidney disease, and cerebral hemorrhage and infarction. Although highly prevalent, the treatment rate (36.9%) and control rate (13.8%) for hypertension are extremely low worldwide. 1 However, high sodium intake is a modifiable risk factor proven to be positively associated with BP, unlike potassium. A study has demonstrated that each one gram increase in 24-hour sodium excretion can increase BP by 4.58/2.25 mmHg, while aleach one gram increase in urinary potassium can decrease systolic blood pressure (SBP) by 3.72 mmHg. 2 Other studies report that reducing sodium intake lowers BP, 3 while potassium depletion leads to an increase in BP. 4 At present, global salt intake is approximately 10 g per day-and 12.5 g per day in China 5 -which exceeds the World Health Organization (WHO) 5 g/day recommendation. 6 Only a few countries meet the daily potassium consumption recommendation proposed by the WHO (upwards of 3510 mg/day). 7 Recent guidelines emphasize lifestyle modification, especially salt reduction and increasing consumption of potassium-rich foods, as one of the first choices of antihypertensive therapy. 8 Several studies have proved salt substitution low in sodium, enriched in potassium and sometimes combined with minerals just like calcium and magnesium may reduce both SBP and diastolic blood pressure (DBP). [9] [10] [11] Research has proved that compared to office blood pressure measurement (OBPM), home blood pressure measurement (HBPM) can be measured more accurately and it is a stronger predictor of cardiovascular outcome, 12 and should be used in the diagnosis and evaluation of hypertension. 8 While numerous studies have reported the positive effect of low-sodium (LS) salt substitution on BP, most of these studies were performed using OBPM or HBPM alone, with only a few conducted by monitoring OBPM and HBPM simultaneously.

A previous study demonstrated sodium-sensitivity of BP was determined by renin 13 ; therefore, we evaluated BP reduction with different levels of renin respond to the LS salt substitution intervention.

This study evaluates the effect of low-sodium salt substitution on OBPM and HBPM in middle-aged and elderly hypertensive patients, and how the effect influenced by plasma renin concentration (PRC).

We enrolled hypertensive outpatients from two community service (2) Renal insufficiency (eGFR < 60 mL/min/1.73m 2 ), acute myocardial infarction, severe heart failure (EF < 50%), or hepatic disease (AST or/and ALT three-fold limitation); (3) Long-term bedridden patient; (4) Using diuretics medication;

(5) A baseline serum potassium concentration of ≥ 5.0 mmol/L.

This is a 12-month prospective, multicenter, randomized, double-blind study. Using a computerized randomization program, the study participants were randomly assigned to one of two groups: the normal salt (NS) group or the LS group, in a 1:1 ratio. The NS group consumed 100% sodium chloride, while the substitution consumed by the LS group was 43% sodium chloride, 32% potassium chloride, and 25% other ingredients.

The participants were asked to replace the salt they used for cooking with the salt provided by the study. The questionnaire was achieved to assess the ordinary salt intake of every family, which would guide the quantity of salt distributed. Every participant also got a 5-g spoon to help them control the amount of salt that was informed used during cooking. Telephone follow-up was conducted every 2 weeks to instruct all the participants to reduce salt during cooking and to assess the use of the salt distributed. The recruiting and assigning work was completed by an assistant who was not in charge of the follow-up, and neither the investigators nor the participants were informed of the assignment until the end of the follow-up period. 

The OBPM was performed at the start of the study, and in the 3 rd , 6 th , and 12 th months. The procedure involved the participants sitting and relaxing for 5 minutes before the measurement was taken using a validated electronic upper-arm cuff device (Contec08D, Qinhuangdao, China). The BP in the right arm was measured thrice, with the patient in a seated position, at one-minute interval, and the average of the last two measurements was used as the OBPM.

All patients received free electronic upper-arm cuff devices (Con-tec08D, Qinhuangdao, China) to measure their BP at home. The HBPM was taught by specialists to the participants and was performed at the start of the study, and in the 3 rd , 6 th , 9 th , and 12 th months. Readings were taken in the morning and evening after participants rested for five F I G U R E 1 Flowchart of the study minutes in a quiet environment on three consecutive appointed days.

Two readings were taken with a 1-minute interval between each reading, and the average of all measurements taken during the three days was calculated and used as the HBPM.

Fasting blood specimens were obtained from each participant at the beginning and at the end of the study period, and fasting spot urine specimens were collected at the beginning, and in the 6 th and 12 th months using urine collection cups and storing tubes. We measured serum sodium, potassium, blood urea nitrogen (BUN), serum creatinine (Scr), uric acid (UA), PRC, aldosterone concentration, urine sodium and potassium levels using the collected samples at the DMU (Dalian Medical University) clinical laboratory. ARR was calculated as the ratio of aldosterone to renin. We used the INTERSALT method to evaluate the 24-hour urinary sodium excretion and Tanaka method to evaluate the 24-hour urinary potassium excretion via spot urinary sodium and potassium. 14-16

The primary outcome was the changes of OBPM and HBPM. The secondary outcome was to compare the BP changes across the three tertile subgroups grouped according to baseline PRC, aldosterone concentration, and aldosterone/renin ratio (ARR).

On the basis of a prior reference, 17 the difference in mean SBP between groups was 4.9 mmHg in that study, sample size estimation was done using the formula

where α was 0.05, and 1 − β was 0.9. The sample size was 160 for each experimental group. Taking 

A total of 352 patients were enrolled, and 30 (8.5%) of these participants withdrew during the intervention stage, while 160 participants in the NS group and 162 in the LS group completed all visits. 

In the first tertile of the PRC subgroup, changes in BP were −8.9 ± 1.6/−7.4 ± 1.3 mmHg; in the second and third tertile, changes in BP were −5.7 ± 2.0/−3.5 ± 1.6 mmHg and −2.2 ± 1.9/−1.4 ± 1.5 mmHg, respectively. BP reduction was greater among the low PRC group than among the high PRC group (P = .002 for change in SBP, P = .016 for change in DBP).

The first tertile of the aldosterone subgroup recorded −6.9 ± Changes in BP among the ARR subgroup were −2.5 ± 1.9/−1.4 ± 1.5, −7.0 ± 2.0/−2.8 ± 1.6, and −8.2 ± 1.7/−6.8 ± 1.4 mmHg for the first, second, and third tertile, respectively. Changes in BP were greater among the high ARR group than among the low ARR group (P = .033 for change in SBP, P = .032 for change in DBP) ( Figure 4A,B) .

At baseline, we observed no significant differences in serum sodium and potassium concentrations between the two groups. At the endpoint of this study, the serum sodium level of the LS group was significantly lower than that of the NS group (P = .030), while the serum potassium level of the LS group was significantly higher than that of the NS group (P < .001). There were no significant differences in the BUN, Scr, and UA of the two groups at baseline and at the endpoint (P > .05) ( Table 2) . None of the participants suffered hyperkalemia or severe deterioration of renal function. Table 3 ).

Our results demonstrate that only systolic OBPM was reduced by lowsodium salt substitution. However, after 12 months of treatment, both systolic and diastolic HBPM were significantly reduced among middleaged and elderly hypertensive patients. Diastolic OBPM was reduced, but not to a significant extent.

A previous clinical trial found that salt substitution significantly reduced office SBP by 8.2 mmHg and DBP by 3.4 mmHg. 18 Another Salt sensitivity is associated with left-ventricular hypertrophy and cardiovascular events, which has been deemed an independent risk factor for cardiovascular disease 27 and mortality. 28 Identifying salt sensitivity may help guide drug therapy 29 and the implementation of salt restriction as a therapeutic method.

Individuals over 50 years old may have a higher salt intake which is due to age-related taste bud deterioration. 5 Thus, elderly patients were expected to have larger effects of LS salt substitution. Many young individuals prefer to eat at the restaurant or at their workplace, which may influence the effect of LS salt substitution on BP among this group. Therefore, we selected middle-aged and elderly patients who ate at least two meals per day at home.

In our study, serum potassium levels increased among the two groups without chronic conditions such as hyperkalemia. Serum sodium levels also increased among both the NS group and the LS group. This may be attributable to conducting the last interview on a hot summer day, which caused patients to sweat-leading to volume loss. 30 The BUN, Scr, and UA levels all changed without significance.

No deterioration of renal function occurred. Thus, we can infer from this study that LS salt substitution is safe for long-term intervention.

By monitoring urine sodium and potassium levels, at the endpoint of this study, we found that the urine sodium levels among the LS group were lower and the potassium levels were higher than the levels among the NS group, with a statistical significance. Therefore, we confirmed the compliance to LS salt substitution by participants in the intervention group.

First, we evaluated the BP responses to LS salt substitution after intervention according to baseline PRC and ARR in middle-aged and elderly participants but not in young participants. Second, we evaluated compliance to LS salt substitution by measuring fasting spot urine sodium and potassium levels, which may not provide the exact sodium and potassium intake.

In conclusions, LS salt substitution is effective in reducing systolic OBPM, systolic HBPM, and diastolic HBPM in middle-aged and elderly hypertensive patients. LS salt substitution may offer a nonpharmaceutical therapy for hypertensive patients. Baseline PRC may be a marker to predict BP response after salt restriction.

This study was supported by National Natural Science Foundation of China (Grant Number: 82070427).

There are no conflicts of interest.

Yinong Jiang contributed to the conception and design of the study.

Li Che contributed to writing the first draft of the manuscript. Wei

Song contributed to the collection of data for the study. Ying Zhang and Yan Lu contributed to data analysis. Yunpeng Cheng contributed to interpretation for the study. All authors revised the manuscript and approved the final version.

Li Che MD https://orcid.org/0000-0003-2664-1300

Wei Song MD https://orcid.org/0000-0002-9900-5834

Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries

Association between urinary sodium and potassium excretion and blood pressure among adults in the United States: national Health and Nutrition Examination Survey

Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH)

Increased blood pressure during potassium depletion in normotensive men

Dietary sodium intake and food sources among Chinese adults: data from the CNNHS

Guideline: Sodium intake for adults and children. World Health Organization (WHO)

Guideline:Potassium intake for adults and children. World Health Organization (WHO)

International Society of Hypertension Global Hypertension Practice Guidelines

Intake of low sodium salt substitute for 3years attenuates the increase in blood pressure in a rural population of North China -A randomized controlled trial

Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension

Long-term effects of salt substitution on blood pressure in a rural north Chinese population

Home blood pressure measurement: a systematic review

Sodium sensitivity of blood pressure in hypertensives is not related to sodium, but rather to renin

Estimating 24-hour urinary sodium excretion from casual urinary sodium concentrations in Western populations: the INTERSALT study

Validity of five formulas in estimating 24-h urinary sodium via spot urine sampling in hypertensive patients living in Northeast China

A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen

Effects of salt substitution on blood pressure using home measurements in essential hypertensive patients: a double-blinded randomized controlled trail

Using a low-sodium, high-potassium salt substitute to reduce blood pressure among Tibetans with high blood pressure: a patient-blinded randomized controlled trial

Effects of salt substitute on home blood pressure differs according to age and degree of blood pressure in hypertensive patients and their families

Effects of dietary sodium substitution with potassium and magnesium in hypertensive type II diabetics: a randomised blind controlled parallel study

Home and office blood pressure monitoring in renal transplant recipients

Marked underestimation of blood pressure control with conventional vs. ambulatory measurements in an urban, developing community of African ancestry

Effect of salt substitution on community-wide blood pressure and hypertension incidence

Effects of salt substitutes on blood pressure: a meta-analysis of randomized controlled trials

Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial

Moderate salt restriction effectively lowers blood pressure and degree of salt sensitivity is related to baseline concentration of renin and N-terminal atrial natriuretic peptide in plasma

Sodium sensitivity and cardiovascular events in patients with essential hypertension

Salt sensitivity, pulse pressure, and death in normal and hypertensive humans

Essential hypertension of Caribbean Hispanics: sodium, renin, and response to therapy

Changes in serum electrolyte levels during marathon running

double-blind clinical trial to evaluate the blood pressure lowing effect of low-sodium salt substitution on middle-aged and elderly hypertensive patients with different plasma renin concentrations